Disclosures for "Glial Fibrillary Acidic Protein in Multiple System Atrophy"
-
Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
-
Ann M. Schmeichel has nothing to disclose.
-
Dr. Misra has nothing to disclose.
-
Miss Griffiths has received personal compensation for serving as an employee of Mayo Clinic.
-
Jennifer Anderson has nothing to disclose.
-
Mr. Sletten has nothing to disclose.
-
Tonette Gehrking has nothing to disclose.
-
Jade Gehrking has nothing to disclose.
-
The institution of Dr. Vemuri has received research support from NIH.
-
Dr. Low has nothing to disclose.